Metagenomi Therapeutics MGX
NASDAQ MGX
$1.12 -0.01 (-0.88%)
As of: Sep 30, 2026 · 1:15 PM EDT

Metagenomi Therapeutics, Inc. (MGX) Asset Utilization Ratio (2024 - 2026)

Updated

Metagenomi Therapeutics' (MGX) Asset Utilization Ratio stood at 0.11 in Q1 2026, down 26.5% from 0.15 a year earlier and down 0.6% from the prior quarter.

Analysis

Metagenomi Therapeutics, Inc. (MGX) Asset Utilization Ratio (2024 - 2026) Analysis & Trends

For FY2025, Metagenomi Therapeutics' Asset Utilization Ratio came in at 0.09, down 39.1% from FY2024.

  • Across earlier years, Asset Utilization Ratio came in at 0.15 in FY2024.
  • The Q1 2026 figure is the lowest quarterly Asset Utilization Ratio in data going back to Q1 2024.
  • On a year-over-year basis, Asset Utilization Ratio has declined for four consecutive quarters, with an average decline of 14.2% over the last five quarters.
  • Per Business Quant, the preceding three quarters came in at 0.11 (Q4 2025), 0.12 (Q3 2025) and 0.12 (Q2 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 0.11
Dec 31, 2025 0.11
Sep 30, 2025 0.12
Jun 30, 2025 0.12
Mar 31, 2025 0.15
Dec 31, 2024 0.15
Sep 30, 2024 0.15
Jun 30, 2024 0.14
Mar 31, 2024 0.12
API Access

Metagenomi Therapeutics, Inc. Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=MGX&period=max&api_key=YOUR_API_KEY